A Dutch guideline for the use of clozapine

Australian and New Zealand Journal of Psychiatry

Volumn 44, Issue 11, 2010, Pages 1055-1056

  Schulte, Peter F J ^a   Cohen, Dan ^a   Bogers, Jan P A M ^b   Van Dijk, Daniel ^c   Bakker, Bert ^d  

^a Mental Health Services North Holland North   (Netherlands)

^b Mental Health Services Rivierduinen   (Netherlands)

^c Mental Health Care Friesland   (Netherlands)

^d Parnassia Bavo Group   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

C REACTIVE PROTEIN; CLOZAPINE; CREATINE KINASE MB; GLUCOSE; HEMOGLOBIN A1C; TROPONIN;

ABNORMAL RESPIRATORY SOUND; AGRANULOCYTOSIS; BLOOD TESTIS BARRIER; CONSTIPATION; DIABETIC KETOACIDOSIS; DYSPNEA; EUROPEAN UNION; FATIGUE; FEVER; GLUCOSE BLOOD LEVEL; GLUCOSE METABOLISM; HUMAN; LETHARGY; LETTER; LEUKOCYTE COUNT; MYOCARDITIS; PERIPHERAL EDEMA; PRACTICE GUIDELINE; PRESCRIPTION; RISK MANAGEMENT; TRAFFIC ACCIDENT; TRICUSPID VALVE REGURGITATION;

AGRANULOCYTOSIS; ANTIPSYCHOTIC AGENTS; CLOZAPINE; HUMANS; LEUKOCYTE COUNT; NETHERLANDS; PRACTICE GUIDELINES AS TOPIC; SCHIZOPHRENIA;

EID: 78049504086     PISSN: 00048674     EISSN: 14401614     Source Type: Journal    
DOI: 10.3109/00048674.2010.514859     Document Type: Letter

References (9)

1. Drew LR. Controls on clozapine must be reviewed. A ust N Z J Psychiatry 2010; 44:490.
2. Netherlands Clozapine Collaboration Group. G uideline for the use of clozapine [English version]. November 2009. [Cited 14 July 2010.] Available from URL:
3. Schulte PFJ. The risk of clozapine-associated agranulocytosis and mandatory white blood cell monitoring. Ann Pharmacother 2006; 40:683-688.
4. Palmer SE, McLean RM, Ellis PM et al . Life-threatening clozapineinduced gastro-intestinal hypomotility: an analysis of 102 cases. J Clin Psychiatry 2008; 69:759-768.
5. Henderson DC, Cagliero E, Copeland PM e t al . Elevated hemoglobin A1c as a possible indicator of diabetes mellitus and diabetic ketoacidosis in schizophrenia patients receiving atypical antipsychotics. J Clin Psychiatry 2007; 68:533-541.
6. Leslie DL, Rosenheck RA. Incidence of newly diagnosed diabetes attributable to atypical antipsychotic medications. Am J Psychiatry 2004; 161:1709-1711.
7. Koller EA, Schneider B, Bennett K, Dubitsky G. Clozapine-associated diabetes mellitus. Am J Med 2001; 11:716-723.
8. Haas SJ, Hill R, Krum H e t al . Clozapine-associated myocarditis: a review of 116 cases of suspected myocarditis associated with clozapine in Australia during 1993-2003. Drug Safety 2007; 30:47-57.
9. Degner D, Bleich S, Grohmann R e t al . Myocarditis associated with clozapine. Aust N Z J Psychiatry 2000; 34:880.